PFE
Pfizer Inc
27.70$
+0.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.0% | 29.7% | 30.1% | 31.3% | 29.5% | 30.6% | 34.6% | 40.1% | 29.2% | 14.6% | 20.0% | 18.7% | |
| 11.2% | 10.6% | 10.9% | 11.9% | 11.9% | 14.6% | 11.5% | 6.4% | 5.0% | 10.6% | 11.0% | 10.5% | |
| 1.2% | 1.4% | 1.3% | 1.6% | 1.8% | 1.7% | 1.8% | 1.5% | 0.9% | 0.9% | 1.4% | 1.3% | |
| 1.5% | 3.7% | 2.1% | -3.4% | -0.4% | 7.0% | 6.9% | -9.0% | -2.7% | – | – | – | |
| 2.9% | 1.2% | 0.2% | 2.5% | -1.7% | -9.8% | -0.7% | 15.8% | -4.4% | -3.6% | -4.8% | -8.6% | |
| 3.2% | 3.1% | 3.8% | 4.2% | 4.1% | 6.3% | 6.7% | 3.3% | 3.2% | 6.6% | 4.6% | 4.2% | |
| -11.4% | -6.1% | -14.8% | -9.0% | 8.4% | -9.6% | -10.3% | -27.7% | -15.7% | -54.2% | 4.2% | -2.2% | |
| 13.3% | 14.2% | 13.9% | 14.6% | 14.9% | 19.5% | 20.3% | 10.7% | 9.0% | 15.5% | 14.9% | 15.6% | |
| -10.1% | -12.6% | -9.5% | -9.5% | -22.7% | -21.5% | 1.0% | 0.0% | -2.0% | 0.0% | 0.0% | – | |
| 1.1% | 2.7% | 4.9% | -1.9% | -1.7% | 21.3% | -30.6% | -1.4% | -3.5% | 60.4% | -11.3% | -0.1% | |
| -20.1% | -20.9% | -16.9% | -24.8% | -38.1% | -20.6% | -23.2% | -12.1% | -14.8% | 43.8% | -26.9% | -16.5% | |
| 2.3% | 0.6% | -2.0% | -2.4% | -0.4% | 0.3% | 1.1% | 0.2% | -1.5% | 4.1% | -2.8% | 0.2% | |
| 30.8% | 26.6% | 26.3% | 27.1% | 25.4% | 24.3% | 27.9% | 36.7% | 25.9% | 8.0% | 15.5% | 14.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.